Non disponible en dehors du Royaume-Uni et de l'Irlande
Biochem/physiol Actions
Galactosyl(β) Ceramide acts as a globotriaosylceramide synthase substrate to produce galabiaosylceramide. Altered levels of this lipid is associated with the development of various diseases including malignancy, sphingolipidosis, diabetes and chronic kidney diseases.
General description
C18(2S-OH) Galactosyl(β) Ceramide, also known as D-galactosyl-β1-1′-N-[2′′(S)-hydroxystearoyl]-D-erythro-sphingosine is a hexosylceramide. Galactosyl(β) Ceramide synthesis is catalyzed by the enzyme β-GalCer synthase (UGT8A).
Packaging
5 mL Amber Glass Screw Cap Vial (860841P-5mg)
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :